Oxford BioMedica plc (GB:OXB)
LSE:OXB
Holding GB:OXB?
Track your performance easily

Oxford BioMedica (OXB) Cash flow

42 Followers

Oxford BioMedica Cash Flow

GB:OXB's free cash flow for Q2 2022 was £―. For the 2022 fiscal year, GB:OXB's free cash flow was decreased by £5.65M and operating cash flow was £―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
-£ -12.60M£ 25.45M£ 3.12M£ -3.51M£ 12.87M
Investing Cash Flow
-£ -56.46M£ -9.46M£ -10.80M£ -19.40M£ -10.10M
Financing Cash Flow
-£ 98.62M£ 46.21M£ 38.19M£ 6.91M£ 15.14M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-£ 141.31M£ 108.94M£ 46.74M£ 16.24M£ 32.24M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-£ 80.15M£ 51.60M£ 41.06M£ 55.48M£ 21.18M
Issuance Of Debt
-£ 25.97M---£ 0.00
Repayment Of Debt
-£ -38.89M-£ 0.00£ -43.59M£ 0.00
Free Cash Flow
-£ 31.11M£ 25.45M£ -10.24M£ -29.28M£ 2.72M
Domestic Sales
------
Foreign Sales
------
Currency in GBP

Oxford BioMedica Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis